Adverum Biotechnologies, Inc (ADVM) insider trading
Every open-market stock purchase and sale by Adverum Biotechnologies, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $765K over the last 12 months (2 buys).
- Insiders sold $4.6M over the last 12 months (2 sales).
- Last insider buy: Laurent Fischer (CEO), $507K, 10 months ago.
Last 12 months: insiders bought $765K (2 buys) and sold $4.6M (2 sales). Last close $4.36 on Dec 8, 2025.
Recent ADVM insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Dec 9, 2025 | Frazier Life Sciences Public Fund L.P. (Insider) | Sold (not open market) | $15.3M |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $1.4M |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $1.2M |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $1.1M |
| Dec 9, 2025 | Linda M Rubinstein (CFO) | Sold (not open market) | $862K |
| Dec 9, 2025 | Scott M Whitcup (Insider) | Sold (not open market) | $769K |
| Dec 9, 2025 | James Paul Scopa (Insider) | Sold (not open market) | $769K |
| Dec 9, 2025 | Patrick Machado (Insider) | Sold (not open market) | $769K |
| Dec 9, 2025 | Mark L. Lupher Jr. (Insider) | Sold (not open market) | $769K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $698K |
| Dec 9, 2025 | Scott M Whitcup (Insider) | Sold (not open market) | $697K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $690K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $684K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $639K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Bought (not open market) | $630K |
| Dec 9, 2025 | Rabia Gurses Ozden (C-suite exec) | Sold (not open market) | $622K |
| Dec 9, 2025 | Patrick Machado (Insider) | Sold (not open market) | $603K |
| Dec 9, 2025 | Mark L. Lupher Jr. (Insider) | Sold (not open market) | $603K |
| Dec 9, 2025 | James Paul Scopa (Insider) | Sold (not open market) | $603K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $593K |
| Dec 9, 2025 | Reed Vaughn Tuckson (Insider) | Sold (not open market) | $578K |
| Dec 9, 2025 | Dawn Svoronos (Insider) | Sold (not open market) | $577K |
| Dec 9, 2025 | Laurent Fischer (CEO) | Sold (not open market) | $461K |
| Dec 9, 2025 | Peter Soparkar (COO) | Sold (not open market) | $460K |
| Dec 9, 2025 | Peter Soparkar (COO) | Sold (not open market) | $456K |
Who's trading ADVM
- Scott M Whitcup, Insider: other filings, last Dec 9, 2025
- Frazier Life Sciences Public Fund L.P., Insider: other filings, last Dec 9, 2025
- Soo Hong, Insider: other filings, last Dec 9, 2025
- Szilard Kiss, Insider: other filings, last Dec 9, 2025
- Laurent Fischer, CEO: bought $554K (2 buys), last Dec 9, 2025
- Mark L. Lupher Jr., Insider: other filings, last Dec 9, 2025
- Patrick Machado, Insider: other filings, last Dec 9, 2025
- C. David Nicholson, Insider: other filings, last Dec 9, 2025
- Rabia Gurses Ozden, C-suite exec: other filings, last Dec 9, 2025
- Linda M Rubinstein, CFO: other filings, last Dec 9, 2025
- James Paul Scopa, Insider: other filings, last Dec 9, 2025
- Setareh Seyedkazemi, C-suite exec: other filings, last Dec 9, 2025
- Peter Soparkar, COO: bought $211K (1 buy), last Dec 9, 2025
- Dawn Svoronos, Insider: other filings, last Dec 9, 2025
- Reed Vaughn Tuckson, Insider: other filings, last Dec 9, 2025
Get free alerts when an insider at Adverum Biotechnologies, Inc files a new trade →